The epoxyketone-based proteasome inhibitors carfilzomib and...

Leukemia 2013 / 2 Vol. 27; Iss. 2

The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects

Hurchla, M A, Garcia-Gomez, A, Hornick, M C, Ocio, E M, Li, A, Blanco, J F, Collins, L, Kirk, C J, Piwnica-Worms, D, Vij, R, Tomasson, M H, Pandiella, A, San Miguel, J F, Garayoa, M, Weilbaecher, K N
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2012.183
Date:
February, 2013
File:
PDF, 1.91 MB
english, 2013
Conversion to is in progress
Conversion to is failed